DS
MDGL icon

David Shaw’s Madrigal Pharmaceuticals MDGL Stock Holding History

David Shaw’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8M Buy
107,700
+30,000
+39% +$15.4M 0.03% 683
2026
Q1 		$40.7M Sell
77,700
-100
-0.1% -$47.8K 0.02% 750
2025
Q4 		$45.3M Buy
77,800
+23,900
+44% +$12.2M 0.02% 762
2025
Q3 		$24.7M Buy
53,900
+30,800
+133% +$11.5M 0.01% 1038
2025
Q2 		$6.99M Buy
23,100
+700
+3% +$209K 0.01% 1769
2025
Q1 		$7.42M Sell
22,400
-47,200
-68% -$15.5M 0.01% 1615
2024
Q4 		$21.5M Buy
69,600
+15,800
+29% +$4.44M 0.02% 996
2024
Q3 		$11.4M Buy
53,800
+8,900
+20% +$2.28M 0.01% 1337
2024
Q2 		$12.6M Sell
44,900
-7,900
-15% -$1.88M 0.01% 1189
2024
Q1 		$14.1M Buy
52,800
+18,300
+53% +$4.31M 0.01% 1141
2023
Q4 		$7.98M Buy
34,500
+10,000
+41% +$1.75M 0.01% 1542
2023
Q3 		$3.58M Buy
24,500
+20,700
+545% +$3.9M ﹤0.01% 2117
2023
Q2 		$878K Hold
3,800
– – ﹤0.01% 3163
2023
Q1 		$921K Buy
+3,800
New +$1.04M ﹤0.01% 3217
2019
Q2 		– Sell
-13,800
Closed -$1.73M – 3774
2019
Q1 		$1.73M Hold
13,800
– – ﹤0.01% 2258
2018
Q4 		$1.56M Buy
13,800
+10,000
+263% +$1.55M ﹤0.01% 2356
2018
Q3 		$814K Buy
+3,800
New +$954K ﹤0.01% 2813

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's MDGL Position: Q2 2026 in Review

David Shaw increased its Madrigal Pharmaceuticals (MDGL) stake by 16% in Q2 2026, buying an estimated $2.53M and bringing the position to 35,071 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #1322.

David Shaw first reported a position in MDGL in Q2 2013 and has held it in 40 quarters since. The position peaked at $51.6M in Q4 2025. 412 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • David Shaw held 35,071 shares of Madrigal Pharmaceuticals worth $18.8M as of Q2 2026.
  • David Shaw bought 4,932 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.53M.
  • Madrigal Pharmaceuticals made up 0.01% of David Shaw's portfolio in Q2 2026, its #1322 holding.
  • David Shaw first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
  • David Shaw's Madrigal Pharmaceuticals position peaked at $51.6M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.